PAFMV-Pairwise Asynchronous Multigrid

Steve Franks,B. McMillin,R. Khanna

Abstract:

What problem does this paper attempt to address?

Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation

Vladimíra Radochová,Martin Šembera,Radovan Slezák,Ondřej Heneberk,Jakub Radocha

DOI: https://doi.org/10.3390/jcm10245790

2021-12-10

Abstract:Background: Hematopoietic stem cell transplantation (HSCT) can induce serious oral complications, including oral mucositis (OM). The presence of periodontal inflammation before HSCT is believed to be associated with OM. The aim of our study was to determine the prevalence and severity of OM in patients undergoing HSCT and its relation to periodontal status. Patients and methods: This is a retrospective study of patients who underwent HSCT and a detailed dental examination between 2007 and 2015. The dental and periodontal status of all patients was evaluated by clinical and radiographic examination prior to HSCT. Oral health was assessed with the gingival index, the the community periodontal index, presence of plaque-related gingivitis, and marginal periodontitis. During the HSCT period, patients were examined daily for the presence of OM, which was graded according to World Health Organization (WHO) classification if present. The patients were assigned to the groups according to type of transplantation: autologous HSCT, myeloablative allogeneic HSCT, and non-myeloablative allogeneic HSCT. Results: A total of 496 patients were included in the study. OM was present in 314 of 496 patients (63.3%): 184/251 (73.3%) in the autologous group, 100/151 (66.2%) in the myeloablative allogeneic group, and 30/94 (31.9%) in the nonmyeloablative allogeneic group. Significantly more patients suffered from OM in the autologous and myeloablative groups versus the nonmyeloablative conditioning group (p < 0.001). The presence of periodontal inflammation did not significantly differ among the groups. There was only a borderline trend for the higher prevalence of OM in the non-myeloablative allogeneic nonmyeloablative group when periodontal inflammation was present (0.073939). Conclusions: Oral mucositis prevalence and severity after stem cell transplantation is not widely affected by the oral hygiene and periodontal disease presence before HSCT. We confirmed the wide-known connection of the conditioning regimen intensity to the prevalence of OM.
Oral squamous cell carcinoma arising from areas of Graft-versus-host disease: A systematic review

M-F Monteiro,J-G Lemos,F-S Pontes,A-C Silva,M-H Silva,N-F Silva,L-L Souza,D-C Uchôa,H-A Pontes,MF. Monteiro,JG. Lemos,FS. Pontes,AC. Silva,MH. Silva,NF. Silva,LL. Souza,DC. Uchôa,HA. Pontes

DOI: https://doi.org/10.4317/medoral.26133

2020-01-01

Medicina Oral Patología Oral y Cirugia Bucal

Abstract:BACKGROUND: Graft-versus-host disease (GVHD) is an immune system reaction that occurs in patients with a history of hematopoietic stem cell transplantation (HSCT), in which the grafted donor's cells attack those of the host. The objective of this systematic review was to present a study on oral squamous cell carcinoma (OSSC) that developed from GVHD areas in patients undergoing HSCT.MATERIAL AND METHODS: An electronic search was conducted in the databases PUBMED, WEB OF SCIENCE, SCOPUS, MEDLINE and SCIENCE DIRECT, according to PRISMA guidelines.RESULTS: Of the 1582 results, 23 articles were included, resulting in 81 cases. The most common underlying disease for performing the transplant was Myeloid Leukemia (55.6%). The mean age was 39 years, with a predilection for males (64.2%). The tongue was the site of GVHD that most frequently underwent transformation to SCC (59.3%). The average time between transplantation and the development of GVHD was of approximately of 8 months, while the average period of development between transplantation and the development of OSCC was of approximately of 111 months. The most common treatment to GVHD was cyclosporine associated with corticosteroids.CONCLUSIONS: OSCCs arising from areas of GVHD present a different evolution from conventional oral carcinomas, since they affect younger patients, smoking and alcohol are not important etiological factors and finally because they present good prognosis, but further studies with larger number cases followed are needed to confirm our findings.

dentistry, oral surgery & medicine
Oral health and hematopoietic stem cell transplantation: A longitudinal evaluation of the first 28 days

Laura M. Doss,Christopher E. Dandoy,Kathi Kramer,Abigail Pate,Laura Flesch,Javier El‐Bietar,Adam Lane,Stella M. Davies,Sarat Thikkurissy,Javier El-Bietar

DOI: https://doi.org/10.1002/pbc.26773

2017-08-26

Abstract:BACKGROUND: Mucositis is well described after pediatric hematopoietic stem cell transplant (HSCT) but other aspects of oral health such as dental plaque and gingivitis are poorly understood. The aim of this study was to describe dental plaque, gingivitis, and mucositis early after HSCT.METHODS: We conducted a prospective longitudinal observational study to describe dental plaque, gingivitis, and mucositis in the peritransplant period. We conducted comprehensive oral evaluations that included the Miyazaki tongue coating, modified simplified oral hygiene, modified gingivitis of Suomi and Barbano, and mucosal ulceration indices at baseline on days 0, +7, +14, and +28.RESULTS: Data were collected from 19 patients with a median age of 8.0 years (5.1-12.8) at time of HSCT. Sixteen patients (85%) had plaque accumulation that progressively worsened, 16 (85%) developed severe gingival inflammation, 13 (68%) developed mucositis, and 11 (58%) had oral ulcerations. All oral indices worsened from baseline during the study period. Gingivitis and oral plaque persisted in most patients at day +28 while mucositis and oral ulcerations slightly improved.DISCUSSION: Gingivitis, dental plaque, mucositis, and oral ulcerations are common after HSCT. Additional studies are needed to ascertain methods that decrease plaque and gingivitis development and severity.

oncology,pediatrics,hematology
Determination of Streptococcus sp. and Candida albicans in the oral cavity of patients undergoing bone marrow transplantation

Evelin Bachmeier,School of Dentistry Chair of Physiology,María Elena Migueles Goitea,Jorge Alberto Linares,Fernando Martín Wietz,Sol Jarchum,Gustavo Jarchum,Mabel Noemí Brunotto,Marcelo Adrián Mazzeo,Sanatorio Allende Department of Oncohematology,School of Dentistry Chair of Cellular Biology “A”,,,,,,,,

DOI: https://doi.org/10.17126/joralres.2021.079

2021-12-31

Journal Of Oral Research

Abstract:Introduction: Chemotherapy can lead to an imbalance in the ecosystem of the oral cavity, allowing the development of mucositis in the immunosuppression phase due to interaction with microbial agents. The objective of this study was to identify bacterial and fungal species that contribute to oral complications in patients undergoing marrow trans-lantation and compare their susceptibility to various antimicrobial agents before and during the immunosuppression period. Material and Methods: This observational-longitudinal study was performed on 18 patients undergoing bone marrow transplantation from the Oncohematology Ser-vice of Sanatorio Allende (2018/2019), with buccal mucosa swabs before treatment (I) and mid-stage (M), fourteen days after transplantation. The samples were cultured in selective media for Streptococcus and fungal species and a susceptibility study was performed on Müller Hinton agar. Results: At (I), 82.30% of patients were found to be positive for Streptococcus mutans, 11.30% for Streptococcus salivarius, 5.50% for Streptococcus sobrinus and 9.40% grew mixed commensal microorganisms. At (M), 96.60% were positive for Streptococcus mutans and 23.10% for Streptococcus salivarius, without any growth of Streptococcus sobrinus or mixed microorganisms. In (I), a 27.00% incidence of Candida albicans was observed, while in (M) the incidence was 73.00%. The antibiotics to which the microorganisms were most sensitive in (I) were vancomycin (88.80%), amikacin (83.30%), amoxicillin + clavulanic acid (78.00%), ciprofloxacin (77.75%) and azithromycin (66.60%). In (M) sensitivity to amikacin was 92.30%, vancomycin, 76.90%; amoxicillin + clavulanic acid, 38.50%; azithromycin, 23.10%; and ciprofloxacin, 15.40%. A statistically significant prevalence of Streptococcus mutans was observed in comparison to other species. Conclusion: During the immunosuppression period, there was a significant increase in Candida albicans. The antibiotics to which the bacteria were most sensitive were amikacin and, to a lesser extent, vancomycin, showing significant resistance to ciprofloxacin, azithromycin and amoxicillin + clavulanic acid.
A Primary Analysis of Oral Mucosa and Periodontal Status of Chronic Graft-Versus-host Disease Caused by Hematopoietic Stem Cell Transplantation

Ke-Jia Lv,Duo-Duo Yan,Guo-Hua Wang,Ya-Nan Yao,Hua Yao

DOI: https://doi.org/10.19439/j.sjos.2018.06.011

2018-01-01

Abstract:PURPOSE:The aim of this study was to investigate the severity and status of oral mucosa and periodontal status in early and late stage after receiving hematopoietic stem cell transplantation(HSCT).METHODS:This study enrolled patients submitted to hematopoietic stem cell transplantation. Through a survey questionnaire, clinical examination, we collected clinical data from 108 HSCT recipients and divided them into 2 groups: transplantation time less than 1 year and more than 1 year. The oral mucosal and periodontal status were recorded and statistically analyzed with SPSS 21.0 software package.RESULTS:The incidence of oral features after HSCT was 78.95%. The incidence of mild symptoms with HSCT less than 1year (n=32) and HSCT more than 1 year (n=43) was 59.38% and 18.60%, respectively. There was significant difference between the two groups (P=0.001).The percent of lichenoid/hyperkeratotic plaques was 31.25% and 60.47%, respectively. The lichenoid/hyperkeratotic plaques were significantly different between the two groups (P=0.012). The detection rate of shallow and moderate pockets was 49.38% and 40.74%, respectively. Visual plaque, calculus and bleeding on probing were 62.96%, 64.20% and 50.62%, respectively.CONCLUSIONS:The incidence of periodontal and mucosal lesions after HSCT is high. The mild symptoms of oral graft versus host disease in early stage are identified obviously, mainly like lichenoid/hyperkeratotic plaques in late stage.
Oral Candida infection and colonization in solid organ transplant recipients

A Dongari-Bagtzoglou,P Dwivedi,E Ioannidou,M Shaqman,D Hull,J Burleson

DOI: https://doi.org/10.1111/j.1399-302X.2009.00505.x

Abstract:Introduction: Oral Candida carriage and infection have been reported to be associated with a greater risk for systemic infection in transplant recipients; however, a systematic analysis of the oral Candida titers and species has not been previously conducted. The objectives of this study were to determine the prevalence of oropharyngeal candidiasis, the oral carrier status, Candida titers and species in this population. Methods: Ninety kidney and heart transplant subjects and 72 age-matched healthy controls were included. Swabs from the oral mucosa and a standardized amount of unstimulated saliva were plated on Chromagar Candida, and colony-forming units per millilitre were calculated. Initial speciation was based on colony color and was confirmed by standard germ tube, biotyping, or polymerase chain reaction assays. Results: Infection with C. albicans was detected in seven transplant subjects and none of the controls. The transplant group had significantly higher oral Candida titers than the control group. There were no statistically significant relationships between the dose or type of immunosuppressants and oral Candida titers or infection. A significantly higher percentage of transplant subjects were colonized by more than one species, compared with control subjects. The most frequent species combination in transplant subjects was C. albicans and C. glabrata. C. glabrata was isolated from 13.5% of transplant carriers and none of the controls. Conclusions: Increased oral Candida infection and carriage titers were found in the transplant population. Although the majority of transplant patients were colonized by C. albicans, C. glabrata appears to emerge as the second most prevalent species.
Studies on the stability of light-sensitive corrinoid-protein complexes.

J. Janicki,F. Pedziwilk,J. Skupin,K. Nowakowska,J. Kowalczyk,K. Trojanowska

Abstract:
Oral and post-transplantation infectious status in patients with hematopoietic stem cell transplants: A prospective observational study

Arife Sabancı,İrfan Kuku

DOI: https://doi.org/10.1016/j.oooo.2022.10.002

Abstract:Objective: Infectious status may be life threatening in hematopoietic stem cell transplant (HSCT) recipients. The aim of this study was to evaluate the effect of oral status on infectious conditions during the neutropenic phase after HSCT. Study design: Seventy patients with various hematologic malignancies were involved. Before HSCT, oral and periodontal examination, including the number of teeth and decayed, missing, and filled teeth index (DMFT); visible plaque (%); bleeding on probing (BOP [%]); clinical attachment level; and probing depth (PD) values were collected. Daily blood cultures were collected and analyzed in terms of infection-related parameters, including febrile neutropenia (FN), bacteremia, and C-reactive protein (CRP) during the neutropenic phase of HSCT. Results: Forty-two patients (60%) received autologous and 28 (40%) allogeneic HSCT. In both groups, patients without FN after HSCT had significantly lower DMFT index scores and fewer sites with PD ≥4 mm (P < .05). However, bacteremia, FN, and CRP were similar in patients with periodontitis compared with non-periodontitis patients (P > .05). Conclusions: The results suggest that periodontal status may not significantly impact the infection-related parameters in patients treated for HSCT. However, DMFT and the prevalence of sites with PD ≥4 mm may be involved in febrile neutropenia.
Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report

Duo Li,Yidan Shan,Weilian Sun,Xiangjian Wang

DOI: https://doi.org/10.7759/cureus.70233

2024-09-26

Cureus

Abstract:Hematopoietic stem cell transplantation (HSCT) is the standard treatment for hematopoietic malignancies and certain solid tumors; however, graft-versus-host disease (GVHD) remains a significant complication. Chronic GVHD (cGVHD), which occurs more than 100 days post-transplant, can lead to various oral manifestations that necessitate multidisciplinary management to prevent disease progression and enhance the quality of life. We present the case of a 60-year-old woman who developed dry mouth, oral pain, a brown-yellow tongue, and dental caries seven years after receiving HLA-matched unrelated donor HSCT. Examination revealed a brown-yellow hairy tongue, extensive tooth decay, reduced saliva production, and oral leukoplakia with mild epithelial hyperplasia, along with dysfunction of the salivary and lacrimal glands. Following appropriate treatment, the patient's symptoms resolved without recurrence at the six-month follow-up. This case highlights the importance of professional diagnosis, timely interventions, and regular monitoring in managing oral cGVHD to achieve a favorable prognosis.
Early and late results of laparoscopic choledochotomy without biliary drainage.

E. Croce,M. Azzola,R. Russo,M. Golia,C. Pompa,D. Ubezio,S. Dal Cin

1993-06-01

Abstract:On account of dissatisfaction with the two-staged approach to stones in the common bile duct, and the risks associated with endoscopic papillotomy, one-stage laparoscopic duct exploration was commenced. The initial experienced with 20 cases is presented. In 13 cases the transcystic approach to the main duct was not successful, so a choledochotomy was performed, and closed without biliary drainage. The postoperative course was similar to laparoscopic cholecystectomy and was uncomplicated in all patients. The follow-up examination of 12 patients demonstrated a mild stenosis of the main duct in our first case; however, this resolved spontaneously within six months. When indicated, the laparoscopic "ideal" choledochotomy with fibroscopic exploration gives very good early and long term results.
[Treatment of inoperable lung carcinoma by means of concentrated radiotherapy: results from 361 cases (author's transl)].

A. Valls Fontanals,H. Pourquier,F. Michel,J. Dubois

1979-03-10

Abstract:In the present work the results of a radiotherapy protocol for the treatment of inoperable lung cancer are examined. The study was carried out on two groups of patients treated successively; the first of 140 patients by means of cobalt therapy at the normal rate, up to a dose of 4,500 to 5,000 rads in 5 weeks; the second of 221 cases by means of concentrated radiotherapy in two series of 2,000 rads in five sessions, separated by 3 weeks of rest. The results show a more rapid regression of the symptomatology in the second group of patients and a clear superiority in respect to the survival rate. The patients treated at the normal rate showed after 6 months a survival rate of 40 percent as against 60.5 percent in the second group. This difference became more evident when comparing the histologic types: 9 and 57 percent respectively for anaplastic carcinomas. The survival rate after 1 year shows a difference between the two groups which is statistically significant (16 and 21 percent respectively) (p less than 0.05). In no case did we find complications of the type of esophagitis, pericarditis or transverse myelitis. The treatment in two sessions was better tolerated both from the physical and the psychic point of view by all the patients because of the 3 weeks of rest. The superiority in regard to survival, the rapid disappearance of the symptomatology, as well as the reduction in the therapy time, justify the use of concentrated radiotherapy in the treatment of this type of tumors even in the more advanced stages of the disease.
[The effect of four immunosuppressive drugs on oral manifestations after organ transplantation]

Wen-Jiao Zhao,Ya-Feng Jin,Ke-Jia Lyu,Duo-Duo Yan,Hua Yao

Abstract:Purpose: To assess the prevalence of oral manifestations in a group of allogenic liver, kidney or haematopoietic stem cell transplantation recipients and patients, and analyze the possible oral manifestations associated with the use of 4 immunosuppressive drugs. Methods: One hundred and eighteen patients submitted to liver, kidney and hematopoietic stem cell transplantation who used tacrolimus， sirolimus，cyclosporine or mycophenolate mofetil were enrolled. Through a questionnaire survey and oral examination, their oral manifestations were recorded, and the possible statistical associations with immunosuppressive drugs were analyzed using SPSS 21.0 software package. Results: The prevalence of oral lichenoid lesions and cheilitis for the group of patients using tacrolimus after transplantation was significantly lower than the group of patients who did not used the agent(P＜0.01). The prevalence of oral lichenoid lesions for the group of patients who used cyclosporine was significantly higher than the group of patients who did not used the drug(P＜0.05), and the prevalence of cheilitis for the group of patients who used cyclosporine was significantly higher than the group of patients who did not used the drug(P＜0.01). The prevalence of oral lichenoid lesions and cheilitis for the group of patients who used tacrolimus was significantly lower than the group of patients who used cyclosporine(P＜0.01). The group of patients who used mycophenolate mofetil after transplantation had a significantly lower prevalence of dry mouth than the group of patients who did not used the drug(P＜0.01). The prevalence of oral manifestations in patients with sirolimus after transplantation was not significantly reduced. Conclusions: The use of tacrolimus improved the symptoms of oral lichenoid lesions and cheilitis and the effect was better than cyclosporine after transplantation. The use of mycophenolate mofetil improved dry mouth after organ transplantation.
RTMIPAS : A fast radiative transfer model for the assimilation of infrared limb radiances from MIPAS

N. Bormann,S. Healy,M. Matricardi

Abstract:An RTTOV-type fast radiative transfer model has been developed for emitted clear-sky limb radiances from the Michelson Interferometer for Passive Atmospheric Sounding (MIPAS) onboard ESA's Envisat. MIPAS is an infrared sounder with very high spectral resolution (0.025 cm, Table 1). It is designed to provide information on the thermal structure and chemical composition of the upper troposphere to lower mesosphere. The fast model is referred to as RTMIPAS, and it has been developed to directly assimilate limb radiances in a global variational data assimilation system (see Bormann and Healy in these proceedings).
Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

M. Faraci,C. Bonaretti,G. Dell’Orso,F. Pierri,S. Giardino,F. Angiero,S. Blasi,G. Farronato,E. Di Marco,A. Trevisiol,E. Olcese,L. Rufino,M. Squillario,R. Biassoni,G. Dell'Orso

DOI: https://doi.org/10.1038/s41598-024-55690-6

IF: 4.6

2024-03-21

Scientific Reports

Abstract:The oral and gastrointestinal mucosae represent the main targets of the toxic effect of chemo and/or radiotherapy administered during the conditioning regimen before hematopoietic stem cell transplant (HSCT). These harmful consequences and the immunological complications that may occur after the transplant (such as Graft versus Host Disease, G v HD) are responsible for the clinical symptoms associated with mucositis during the aplasia phase, like pain, nausea, vomiting, and diarrhea. These toxicities could play a critical role in the oral and gastrointestinal microbiomes during the post-transplant phase, and the degree of microbial dysbiosis and dysregulation among different bacterial species could also be crucial in intestinal mucosa homeostasis, altering the host's innate and adaptive immune responses and favoring abnormal immune responses responsible for the occurrence of G v HD. This prospective pediatric study aims to analyze longitudinally oral and gut microbiomes in 17 pediatric patients who received allogeneic HSCT for malignant and non-malignant diseases. The oral mucositis was mainly associated with an increased relative abundance of Fusobacteria , and Prevotella species, while Streptococcus descendants showed a negative correlation. The fecal microbiome of subjects affected by cutaneous acute G v HD (aG v HD) correlated with Proteobacteria . Oral mucosal microbiota undergoes changes after HSCT, Fusobacteria, and Prevotella represent bacterial species associated with mucositis and they could be the target for future therapeutic approaches, while fecal microbiome in patients with acute G v HD (aG v HD) revealed an increase of different class of Proteobacteria ( Alphaproteobacteria and Deltaproteobacteria ) and a negative correlation with the class of Gammaproteobacteria .

multidisciplinary sciences
Effects of bacterial direct-fed microbials on ruminal characteristics, methane emission, and milk fatty acid composition in cows fed high- or low-starch diets.

Christelle Philippeau,A. Lettat,Cécile Martin,Mathieu Silberberg,D. Morgavi,A. Ferlay,C. Berger,P. Nozière

DOI: https://doi.org/10.3168/jds.2016-11663

IF: 4.225

2017-04-01

Journal of Dairy Science

Abstract:This study investigated the effects of bacterial direct-fed microbials (DFM) on ruminal fermentation and microbial characteristics, methane (CH4) emission, diet digestibility, and milk fatty acid (FA) composition in dairy cows fed diets formulated to induce different ruminal volatile fatty acid (VFA) profiles. Eight ruminally cannulated dairy cows were divided into 2 groups based on parity, days in milk, milk production, and body weight. Cows in each group were fed either a high-starch (38%, HS) or a low-starch (2%, LS) diet in a 55:45 forage-to-concentrate ratio on a dry matter (DM) basis. For each diet, cows were randomly assigned to 1 of 4 treatments in a Latin square design of (1) control (CON); (2) Propionibacterium P63 (P63); (3) P63 plus Lactobacillus plantarum 115 (P63+Lp); (4) P63 plus Lactobacillus rhamnosus 32 (P63+Lr). Strains of DFM were administered at 1010 cfu/d. Methane emission (using the sulfur hexafluoride tracer technique), total-tract digestibility, dry matter intake, and milk production and composition were quantified in wk 3. Ruminal fermentation and microbial characteristics were measured in wk 4. Data were analyzed using the mixed procedure of SAS (SAS Institute Inc., Cary, NC). The 2 diets induced different ruminal VFA profiles, with a greater proportion of propionate at the expense of acetate and butyrate for the HS diet. Greater concentrations of total bacteria and selected bacterial species of methanogenic Archaea were reported for the HS diet, whereas the protozoa concentration in HS decreased. For both diets, bacterial DFM supplementation raised ruminal pH (+0.18 pH units, on average) compared with CON. Irrespective of diet, P63+Lp and P63+Lr increased ruminal cellulase activity (3.8-fold, on average) compared with CON, but this effect was not associated with variations in ruminal microbial numbers. Irrespective of diet, no effect of bacterial DFM on ruminal VFA was observed. For the LS diet, supplementing cows with P63+Lr tended to decrease CH4 emission (26.5%, on average, when expressed per kilogram of milk or 4% fat-corrected milk). Only P63 supplementation to cows fed the HS diet affected the concentration of some milk FA, such as cis isomers of 18:1 and intermediates of ruminal biohydrogenation of polyunsaturated FA. Overall, bacterial DFM could be useful to stabilize ruminal pH. Their effects on CH4 production mitigation and milk FA profile depended on DFM strain and diet and should be confirmed under a greater variation of dietary conditions.
Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors

Stefan Wuketich,Stefan A Hienz,Christine Marosi

DOI: https://doi.org/10.1007/s00520-011-1107-y

Abstract:Purpose: Chemotherapy-induced oral mucositis (CIOM) is a common side effect of cancer therapy that may lead to significant morbidity and interfere with the treatment plan. The present prospective, cross-sectional study intended to describe the prevalence of clinically relevant CIOM (CRCIOM) in outpatients receiving chemotherapy for solid tumors. Methods: Intra-oral assessments were performed on 298 consecutively recruited patients, who had undergone at least 14 days of chemotherapy for solid tumors in our outpatient oncology department. The presence of CIOM was evaluated using the Oral Mucositis Assessment Scale. CRCIOM was defined as the presence of ulcers (≥ 1 cm(2)), severe erythema, and/or inability to eat solid foods (WHO grades 2-4). Furthermore, the current levels of oral hygiene and oral health were measured. Results: A low prevalence (18 patients, 6%) of CRCIOM was found in the investigated patient collective, including 1% of patients with severe (WHO grade 3/4) CIOM. In the CRCIOM group, 16 patients were male, and two were female; 8 patients with CRCIOM had received head and neck radiotherapy. A higher prevalence of CRCIOM was found in smoking patients (12.7% vs. 4.5%, p < 0.05) and in the patients who have not had a dental checkup within the preceding 12 months (11.2% vs. 3.0%, p < 0.01). Diabetes mellitus and low WBC appeared not to be associated with higher CRCIOM rates. The plaque and gingival indexes were significantly increased (p < 0.01) in the CRCIOM group. Conclusions: Although CRCIOM was a rare event in the investigated patient population, our results emphasize that pre-treatment dental therapy and primary preventive measures (including oral hygiene instructions) can be improved. Before starting chemotherapy, increased awareness of individual risk factors, such as male sex, tobacco smoking, low dental checkup frequency, poor oral hygiene, and a reduced oral health status, could help to prevent CRCIOM.
Prevalence and risk factors of chronic oral complications in head and neck cancer therapies: A retrospective study

E Benito-Ramal,A Camacho-Mourelo,B González-Navarro,J-L López,E Jané-Salas

DOI: https://doi.org/10.4317/medoral.26823

2024-11-01

Abstract:Background: Oncological therapy can trigger various complications and side effects in certain tissues, such as the oral cavity, inducing a direct or indirect impact on basic functions and the patient's quality of life. The aim of the study is to determine the prevalence of chronic oral complications of oncological treatments in patients with head and neck cancer and assess their possible relationship with risk indicators associated with the patient, the tumor, and the treatment. Material and methods: A retrospective, single-center, observational pilot cohort study was designed at the Dental Hospital of the University of Barcelona, involving patients with head and neck cancer who underwent surgery, non-surgical oncological therapy (radiotherapy/chemotherapy/immunotherapy), or combined therapy. Medical histories were analyzed, and data related to demographics, toxic, hygienic, and dietary habits, systemic and oral health status, characteristics of cancer and its treatment, and registered chronic oral complications were collected. The results were expressed in descriptive measures (means, standard deviations, counts, prevalence, and 95% confidence intervals), and for statistical associations, parametric and non-parametric tests were used. Results: The overall prevalence of chronic oral complications was 92.57%. Dental disease (81.14%), periodontal disease (65.14%), and hyposalivation/xerostomia (62.86%) showed the highest prevalence. Advanced age, certain cancer locations, advanced cancer stages, and oncological therapy including radiotherapy were significantly associated with the presence and number of complications. Conclusions: The elevated noticed prevalence necessitates rigorous monitoring and preventive care. The combination of risk factors can significantly contribute to oral complications. Understanding these factors services dentists establish protocols for preventing, diagnosing, and treating oncology patients.
Persistent Changes of Peripheral Blood Lymphocyte Subsets in Patients with Oral Squamous Cell Carcinoma

Ana Caruntu,Liliana Moraru,Mihaela Surcel,Adriana Munteanu,Daniel Octavian Costache,Cristiana Tanase,Carolina Constantin,Cristian Scheau,Monica Neagu,Constantin Caruntu

DOI: https://doi.org/10.3390/healthcare10020342

2022-02-10

Health Care

Abstract:Background: Oral squamous cell carcinoma (OSCC) is a common cancer with high morbidity and mortality. Alterations of antitumor immune responses are involved in the development of this malignancy, and investigation of immune changes in the peripheral blood of OSCC patients has aroused the interest of researchers. Methods: In our study, we assessed the proportions of CD3+ total T lymphocytes, CD3+CD4+ helper T lymphocytes, CD3+CD8+ suppressor/cytotoxic T lymphocytes, CD3−CD19+ total B lymphocytes, and CD3−CD16+CD56+ NK cells in the peripheral blood of OSCC patients. Results: The data obtained both pre- and post-therapy showed a similar level of total CD3+ T lymphocytes in OSCC patients and control subjects, pinpointing the stability of this immune parameter. On the other hand, pre-therapeutic data showed a lower proportion of helper T lymphocytes (CD4+), a significantly higher level of cytotoxic/suppressive T lymphocytes (CD8+), and a much lower CD4+ T lymphocyte/CD8+ T lymphocyte ratio compared to control subjects. Conversely, evaluation of circulating NK (CD16+) cells showed a markedly higher pre-therapeutic level compared to the control group. Conclusions: Our results related to immune changes in the peripheral blood add new information to this complex universe of connections between immuno-inflammatory processes and carcinogenesis.

health care sciences & services,health policy & services
A systematic review of dental disease in patients undergoing cancer therapy

Catherine H L Hong,Joel J Napeñas,Brian D Hodgson,Monique A Stokman,Vickie Mathers-Stauffer,Linda S Elting,Fred K L Spijkervet,Michael T Brennan,Dental Disease Section, Oral Care Study Group, Multi-national Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)

DOI: https://doi.org/10.1007/s00520-010-0873-2

Abstract:Introduction: This purpose of this systematic review was to evaluate the literature and update our current understanding of the impact of present cancer therapies on the dental apparatus (teeth and periodontium) since the 1989 NIH Development Consensus Conference on the Oral Complications of Cancer Therapies. Review method: A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between 1 January 1990 and 31 December 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of dental caries, severe gingival disease, and dental infection. Data on DMFT/dmft, DMFS/dmfs, plaque, and gingival indexes were also gathered. The level of evidence, recommendation, and guideline (if possible) were given for published preventive and management strategies. Results: Sixty-four published papers between 1990 and 2008 were reviewed. The weighted overall prevalence of dental caries was 28.1%. The overall DMFT for patients who were post-antineoplastic therapy was 9.19 (SD, 7.98; n = 457). The overall plaque index for patients who were post-antineoplastic therapy was 1.38 (SD, 0.25; n = 189). The GI for patients who were post-chemotherapy was 1.02 (SD, 0.15; n = 162). The weighted prevalence of dental infections/abscess during chemotherapy was reported in three studies and was 5.8%. Conclusions: Patients who were post-radiotherapy had the highest DMFT. The use of fluoride products and chlorhexidine rinses are beneficial in patients who are post-radiotherapy. There continues to be lack of clinical studies on the extent and severity of dental disease that are associated with infectious complications during cancer therapy.
Oral malignant and potentially malignant lesions after allogenic hematopoietic cell transplantation: a 10-year follow-up study

H. Mawardi,S. Elad,Y. Zadik,M. E. Correa,O. Felemban,N. S. Treister

DOI: https://doi.org/10.1038/s41409-024-02443-8

2024-10-20

Bone Marrow Transplantation

Abstract:Allogeneic hematopoietic cell transplantation (alloHCT) is a treatment option for patients with hematological malignancies and other non-malignant conditions [1]. Even with improved outcomes, alloHCT recipients may experience late complications with significant impact on quality of life and mortality [2, 3]. Oral and cutaneous squamous cell carcinoma have been reported as the most common solid cancers in alloHCT survivors [4]. We previously reported 26 patients with oral malignant or oral potentially malignant disorders (OPMD) following alloHCT, in which 44% experienced local recurrence after management [5]. The present report provides a 10-year follow up of this cohort. We previously reported an international multicenter cohort of patients who received alloHCT and subsequently developed OPMDs or oral malignancy (OM) [5]. This retrospective study was approved by the institutional review boards at each participating center which included (1) Dana-Farber/Brigham and Women's Cancer Center, Boston, USA; (2) Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and (3) Bone Marrow Transplant Center, State University of Campinas, Campinas, Brazil.

oncology,immunology,hematology,transplantation

PAFMV-Pairwise Asynchronous Multigrid

Oral Mucositis Association with Periodontal Status: A Retrospective Analysis of 496 Patients Undergoing Hematopoietic Stem Cell Transplantation

Oral squamous cell carcinoma arising from areas of Graft-versus-host disease: A systematic review

Oral health and hematopoietic stem cell transplantation: A longitudinal evaluation of the first 28 days

Determination of Streptococcus sp. and Candida albicans in the oral cavity of patients undergoing bone marrow transplantation

A Primary Analysis of Oral Mucosa and Periodontal Status of Chronic Graft-Versus-host Disease Caused by Hematopoietic Stem Cell Transplantation

Oral Candida infection and colonization in solid organ transplant recipients

Studies on the stability of light-sensitive corrinoid-protein complexes.

Oral and post-transplantation infectious status in patients with hematopoietic stem cell transplants: A prospective observational study

Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report

Early and late results of laparoscopic choledochotomy without biliary drainage.

[Treatment of inoperable lung carcinoma by means of concentrated radiotherapy: results from 361 cases (author's transl)].

[The effect of four immunosuppressive drugs on oral manifestations after organ transplantation]

RTMIPAS : A fast radiative transfer model for the assimilation of infrared limb radiances from MIPAS

Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

Effects of bacterial direct-fed microbials on ruminal characteristics, methane emission, and milk fatty acid composition in cows fed high- or low-starch diets.

Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors

Prevalence and risk factors of chronic oral complications in head and neck cancer therapies: A retrospective study

Persistent Changes of Peripheral Blood Lymphocyte Subsets in Patients with Oral Squamous Cell Carcinoma

A systematic review of dental disease in patients undergoing cancer therapy

Oral malignant and potentially malignant lesions after allogenic hematopoietic cell transplantation: a 10-year follow-up study